| |
| Issue |
Title |
| |
| Vol 65, No 3 (2025) |
Possibilities of Optimizing Drug Therapy for Myocardial Infarction: a Consensus on the Use of Type 2 Sodium-Glucose Co-Transporter Inhibitors. Conciliation Document of the Expert Group |
Abstract
|
|
G. P. Arutyunov, S. K. Kononov, N. I. Novitskii, A. N. Baglikov, A. A. Shchendrygina, E. A. Kuzheleva, K. A. Eruslanova, V. A. Safronenko, K. V. Kop’eva, A. E. Soloveva |
| |
| Vol 61, No 10 (2021) |
Expert opinion. Spironolactone: a new twist on an old story |
Abstract
PDF (Rus)
|
|
Ya. A. Orlova, Yu. L. Begrambekova, A. G. Plisuk |
| |
| Vol 61, No 4 (2021) |
Clinical Efficacy and Mechanisms of Actions of the Glucagon-Like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus and High Risk of Cardiovascular Diseases |
Abstract
PDF (Rus)
|
|
S. R. Gilarevsky |
| |
| Vol 57, No 8 (2017) |
Randomized Controlled Trials in Patients With Heart Failure in Russia Following the Study TOPCAT: What Awaits us in the Future |
Details
PDF (Rus)
|
|
Yuri M. Lopatin |
| |
| 1 - 4 of 4 Items |
|
